Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab
对接受新辅助曲妥珠单抗联合或不联合帕妥珠单抗化疗的ERBB2阳性乳腺癌患者进行基因组检测的评估
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.0187
Bueno-Muiño, Coralia; Echavarría, Isabel; López-Tarruella, Sara; Roche-Molina, Marta; Del Monte-Millán, María; Massarrah, Tatiana; Jerez, Yolanda; Ayala de la Peña, Francisco; García-Sáenz, José Ángel; Moreno, Fernando; Rodríguez-Lescure, Álvaro; Malón-Giménez, Diego; Ballesteros García, Ana Isabel; Marín-Aguilera, Mercedes; Galván, Patricia; Brasó-Maristany, Fara; Waks, Adrienne G; Tolaney, Sara M; Mittendorf, Elizabeth A; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S; Perou, Charles M; Paré, Laia; Villacampa, Guillermo; Prat, Aleix; Martín, Miguel